about
Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasiaInflammation-based factors and prognosis in patients with colorectal cancerA human tRNA methyltransferase 9-like protein prevents tumour growth by regulating LIN9 and HIF1-αThe UMD-APC database, a model of nation-wide knowledge base: update with data from 3,581 variations.Proteome analysis of butyrate-treated human colon cancer cells (HT-29).Inter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: implications for chemoresistanceModeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliabilityTowards a molecular understanding of polycythemia rubra vera.Oncogenic Ras promotes butyrate-induced apoptosis through inhibition of gelsolin expression.Methylation and colorectal cancer.Prognostic and predictive response factors in colorectal cancer patients: between hope and reality.Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy.Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instabilityColorectal cancer: from epidemiology to current treatment.Pathogenesis and clinical management of hereditary non-polyposis colorectal cancer.Detailed deletion mapping of loss of heterozygosity on 22q13 in sporadic colorectal cancer.Modern management of colorectal cancer--a pathologist's view.Effects of hemin and nitrite on intestinal tumorigenesis in the A/J Min/+ mouse model.A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening roundsAn insight into the genetic pathway of adenocarcinoma of the small intestineMicrosatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosisAnalysis of hypermethylation and expression profiles of APC and ATM genes in patients with oral squamous cell carcinoma.Spontaneous aberrant crypt foci in Apc1638N mice with a mutant Apc allele.Expression Profiles in Stage II Colon Cancer According to APC Gene Status.Colon cancer: prevalence, screening, gene expression and mutation, and risk factors and assessment.The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study.Differential gene expression of chemokines in KRAS and BRAF mutated colorectal cell lines: role of cytokines.Signature of microsatellite instability, KRAS and BRAF gene mutations in German patients with locally advanced rectal adenocarcinoma before and after neoadjuvant 5-FU radiochemotherapy.Spontaneous initiation, promotion and progression of colorectal cancer in the novel A/J Min/+ mouse.Effects of carrot and tomato juice consumption on faecal markers relevant to colon carcinogenesis in humans.Comparison of blood neoangiogenesis and lymphatic vascularization in colorectal adenomas from patients with and without concomitant colorectal cancer.Sulindac and Celecoxib regulate cell cycle progression by p53/p21 up regulation to induce apoptosis during initial stages of experimental colorectal cancer.Quantitative analysis of plasma DNA in colorectal cancer patients: a novel prognostic tool.Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines.[Carcinogenesis and hereditart colon cancers].Association of Genetic Defects in Primary Resected Lung Adenocarcinoma Revealed by Targeted Allelic Imbalance Analysis
P2860
Q24679141-63CFB071-EED7-4F67-9F4C-8269A27F1EB3Q26797425-2B08A09F-08EC-4E6D-B99E-3D29CE4A8196Q28115094-D06F696D-8908-4564-971F-DC215BA428A4Q30771579-FABA91C8-B6D8-4BFB-B3FB-0278D2E43DBBQ31045932-FEF6663C-C34A-4516-9E9E-9E269923B8BFQ33245747-DD6DEA1E-84DC-4AA2-976D-B24818312183Q33721845-B5EE89E2-13EB-4015-9A24-2F926A5CC98BQ33940318-6FF9353C-9A0D-4FF2-9F52-F4C1B982CA9DQ34328635-1BDBC2E3-D731-419E-9E90-8F35F7F21696Q34378429-C3CC1F58-8915-42E7-9247-BA7CA29AF8E5Q34467133-54E24CA5-EB7E-4B80-9A17-C5AD615C66F1Q34573748-2C2CFED6-24A4-486E-A869-E2AF5181D150Q34768295-8967154C-B051-43DC-9F04-55539618B8CDQ34844579-9A539A95-1B45-4542-A475-1653553680FEQ34975960-10E4EE6C-7B9F-4378-B30D-2F21948BACEDQ35011398-AE82AFDD-31D5-4C97-A483-B718A7A57432Q35111158-6338AD56-BC0E-4225-94FA-7FB5800D0982Q35251212-371DAD3B-1428-45FA-939D-5C01528C11EFQ35594301-5A0BCE32-E4D7-4CED-8D36-952F335ED370Q35594366-E70C660B-7B68-488F-8B0C-728B2649509AQ35746560-EFF3687D-A987-4194-9B0B-F341DFA43FF5Q35829433-3F2084D5-2976-450F-A750-9E867242C60CQ35843426-455E6994-6AFC-402F-977C-6FA1659069DFQ35882231-3FEF710D-6DA0-4D4B-9D80-DAA8441E644CQ36104060-DEC06E05-AD33-4A6C-A9D8-94307D9D8856Q36615234-75997141-17DE-4EE6-A575-19FF320A4BEEQ37385280-1EDDC651-D9CC-4624-A352-C175B690A4A2Q38366270-D7F2A5B1-2C76-43FD-B383-C461AF28CA3EQ40072841-88E732BF-3996-473A-9EB5-2E198F17A12AQ40910324-E4BCE688-7941-4A4B-8530-7A64E624F4DCQ46768372-6297E7F2-1906-437B-A4B2-2282E0598A25Q47733549-32E34F2D-2A2A-4464-86C2-51F48C6EA4E1Q48001444-BD2F8314-DCF5-4A0C-8102-0CC257203253Q51104081-32172965-B2CD-4984-AF04-EA2231D4BD5BQ52826936-5C9A9694-1E7C-4983-B0B0-E5E5FE83E4A5Q54525841-A598D44A-D329-4E1B-B587-505A139CA615Q57259657-A8BA09BC-48FF-48FD-8834-BBBE25DD0A94
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Genetic pathways in colorectal and other cancers.
@ast
Genetic pathways in colorectal and other cancers.
@en
type
label
Genetic pathways in colorectal and other cancers.
@ast
Genetic pathways in colorectal and other cancers.
@en
prefLabel
Genetic pathways in colorectal and other cancers.
@ast
Genetic pathways in colorectal and other cancers.
@en
P2093
P1476
Genetic pathways in colorectal and other cancers.
@en
P2093
P304
P356
10.1016/S0959-8049(98)00431-6
P577
1999-03-01T00:00:00Z